OBJECTIVE The association between changes in triglyceride concentrations over time and diabetes is unknown.
We next evaluated the association between changes in triglyceride levels and diabetes risk.
The close association observed between changes in triglyceride levels and alterations in BMI, physical activity, and eating habits (13) suggests triglyceride level as a sensitive lifestyle biomarker that is relevant to diabetes risk assessment.
Similarly, we found no association between change in triglycerides and risk of coronary heart disease events whenever the model included an adjustment for the change in low density lipoprotein cholesterol (data available from the authors).
There was no correlation between changes in plasma triglyceride levels and tHcy levels.
Although we observed a modest improvement in post-meal plasma and chylomicron triglyceride concentrations with pre-meal prandial + basal over the first 3 h of the post-meal period, we did not see a relationship between changes in plasma triglyceride concentrations and changes in inflammatory markers or glycative stress.
This study investigates the associations between changes in serum Triglycerides (S-TG), -Urate (S-Urate), and -Glucose (S-Glu) and changes in serum Calcium (S-Ca), -Magnesium (S-Mg), and -Phosphate (S-P) in patients with type 2 diabetes compared with non-diabetic patients.
This study tests whether there is a link between changes in serum Triglycerides (S-TG), -Urate (S-Urate), and -Glucose (S-Glu) and changes in serum Calcium (S-Ca), -Magnesium (S-Mg), or -Phosphate (S-P) over time and identifies if and how any associations are specific for either type 2 diabetes or the non-diabetes condition after stratification for sex.
Another study, also using a standard commercial meal, reported no correlation between changes in post-meal triglycerides and those of hsCRP and IL-6 [ 16].
The independent variables were age, sex, body mass index (BMI), disease duration, and differences between changes in blood glucose AUC, changes in triglycerides CV, and changes in HDL-C CV without exenatide compared with exenatide administration.
Interestingly, the association between rosiglitazone use and changes in LDL2 or LDL4 was not accounted for by changes in triglyceride or HDL cholesterol levels, but was attenuated after adjustment for changes in adiponectin concentrations.
